@trevor.wdavis's TRT cycle breakdown, fact-checked
Quick answer
This video discloses a multi-compound pre-contest anabolic stack including supraphysiologic testosterone (500mg/week), Trenbolone (300mg/week), Masteron (300mg/week), three oral androgens stacked simultaneously, 8 IU of growth hormone daily, and 120mcg of Clenbuterol, a beta-2 agonist with cardiac toxicity risk at high doses that carries no approved human indication in the United States. The combined cardiovascular, hepatic, and metabolic load of this stack exceeds what standard outpatient blood work panels are designed to detect or monitor. Any clinician evaluating a patient influenced by this content should screen for early markers of androgen-associated cardiomyopathy, hepatotoxicity from oral androgen stacking, and electrolyte abnormalities consistent with clenbuterol use.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @trevor.wdavis actually say?
Trevor Davis, two weeks out from what he describes as his first pro bodybuilding show, laid out his full contest prep stack on camera. No hedging, no disclaimers buried in fine print. He listed 500mg of testosterone per week, 300mg of Masteron, 300mg of Trenbolone, 50mg daily of Anavar, Proviron, and Winstrol stacked together, 8 IU of growth hormone daily, and 120 micrograms of Clenbuterol. He framed it explicitly as personal disclosure, not advice, saying "this isn't advice, this is my prep and my cycle." He also acknowledged this is "built off experience, blood work, and knowing exactly what my body responds to." That self-awareness matters, but it doesn't change what the audience actually walks away with.
Credit where it's due: he didn't claim you could replicate this look naturally. He explicitly rejected that framing. That's more honest than a lot of what circulates in this space.
Does the science back up his compound rationale?
Some of it is physiologically coherent. Some of it is bro-science dressed up in confident delivery. The claims about individual compounds are directionally correct in places, but the combined picture is where the risk math gets uncomfortable.
Testosterone at 500mg per week produces supraphysiologic androgen levels. That's not controversial. A 2001 study by Bhasin et al. in the New England Journal of Medicine established dose-dependent increases in muscle mass and strength at supraphysiologic testosterone doses, with side effects scaling accordingly. Trenbolone's reputation for "dense" muscle and aggression has real androgenic pharmacology behind it, though human clinical trial data is thin because no institution is running controlled trenbolone trials on athletes. Most of what exists is veterinary research and case reports.
Clenbuterol at 120 micrograms daily is at the high end of ranges documented in the literature. A 2012 review by Kamalakkannan et al. in Cardiovascular Toxicology documented cardiac hypertrophy and arrhythmia risk with clenbuterol misuse. The claim that it's "pushing fat loss to the edge" is accurate in the sense that it's also pushing cardiac stress to the edge. Those two things are not separable at that dose.
8 IU of growth hormone daily for a non-deficient adult is aggressive. Studies like Blackman et al. (2002, JAMA) showed GH supplementation in healthy older adults produced body composition changes alongside meaningful rates of adverse effects including edema, joint pain, and glucose dysregulation.
What did he get wrong, or right?
He got the individual compound rationales roughly right in the sense that they map to known pharmacological mechanisms. Masteron as an anti-estrogenic hardening agent, Winstrol and Anavar for strength-to-weight ratio in a caloric deficit, growth hormone for recovery and body composition, these are all consistent with how these compounds actually work.
What he glossed over is additive cardiovascular load. Stacking multiple androgens with a beta-2 agonist and supraphysiologic GH simultaneously creates a cardiovascular stress profile that is not the sum of its parts. Baggish et al. (2017, Circulation) found that long-term anabolic steroid use was associated with left ventricular dysfunction and reduced myocardial function even in experienced users who cycled. He mentioned blood work as his safety net, but standard metabolic panels don't capture early myocardial remodeling.
He was right to say "don't be reckless." He was wrong to imply that experience and blood work are sufficient safeguards for a stack of this complexity. They lower the risk. They don't neutralize it.
What should you actually know?
This video will reach people who are not two weeks out from a pro bodybuilding show. It will reach 20-year-olds who want to look like Trevor Davis and will treat this disclosure as a blueprint. That's the real issue, not whether Trevor himself understands his own cycle.
A few things the video does not tell you:
- Trenbolone has no approved human use. All human use is off-label and unsupported by clinical safety trials.
- Clenbuterol is not approved for human use in the United States. Its use in athletes has been associated with hospital admissions for tachycardia and hypokalemia.
- The cardiovascular risk profile of combined androgen stacking is cumulative and not fully reversible. Research by Rasmussen et al. (2016, European Heart Journal) found persistently impaired heart function in former steroid users compared to controls, years after stopping.
- "Blood work" as commonly run by athletes does not screen for early cardiac remodeling or microvascular coronary disease.
- 8 IU of GH daily in a non-deficient individual carries real risk of acromegalic changes, insulin resistance, and soft tissue complications with prolonged use.
Trevor Davis is not a villain here. He's a competitive athlete being transparent about choices he's making for himself, in a sport where these choices are functionally normalized. But transparency about a high-risk stack is not the same as safety, and 54,000 views means this information is landing in a lot of contexts where those distinctions get lost.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @trevor.wdavis's TRT cycle breakdown, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@trevor.wdavis's TRT cycle breakdown, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
This video discloses a multi-compound pre-contest anabolic stack including supraphysiologic testosterone (500mg/week), Trenbolone (300mg/week), Masteron (300mg/week), three oral androgens stacked simultaneously, 8 IU of growth hormone daily, and 120mcg of Clenbuterol, a beta-2 agonist with cardiac toxicity risk at high doses that carries no approved human indication in the United States.
FormBlends verdict
This video discloses a multi-compound pre-contest anabolic stack including supraphysiologic testosterone (500mg/week), Trenbolone (300mg/week), Masteron (300mg/week), three oral androgens stacked simultaneously, 8 IU of growth hormone daily, and 120mcg of Clenbuterol, a beta-2 agonist with cardiac toxicity risk at high doses that carries no approved human indication in the United States. The combined cardiovascular, hepatic, and metabolic load of this stack exceeds what standard outpatient blood work panels are designed to detect or monitor. Any clinician evaluating a patient influenced by this content should screen for early markers of androgen-associated cardiomyopathy, hepatotoxicity from oral androgen stacking, and electrolyte abnormalities consistent with clenbuterol use.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- This video discloses a multi-compound pre-contest anabolic stack including supraphysiologic testosterone (500mg/week), Trenbolone (300mg/week), Masteron (300mg/week), three oral androgens stacked simultaneously, 8 IU of growth hormone daily, and 120mcg of Clenbuterol, a beta-2 agonist with cardiac toxicity risk at high doses that carries no approved human indication in the United States. The combined cardiovascular, hepatic, and metabolic load of this stack exceeds what standard outpatient blood work panels are designed to detect or monitor. Any clinician evaluating a patient influenced by this content should screen for early markers of androgen-associated cardiomyopathy, hepatotoxicity from oral androgen stacking, and electrolyte abnormalities consistent with clenbuterol use.
- Bhasin et al. (2001, NEJM) confirmed supraphysiologic testosterone increases muscle and strength, but side effects including cardiovascular strain scale with dose, not just benefit.
- Trenbolone carries zero approved human clinical trial data. Every safety and efficacy claim about it in humans is derived from anecdote, case reports, or veterinary research.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Bhasin et al. (2001, NEJM) confirmed supraphysiologic testosterone increases muscle and strength, but side effects including cardiovascular strain scale with dose, not just benefit.
- Trenbolone carries zero approved human clinical trial data. Every safety and efficacy claim about it in humans is derived from anecdote, case reports, or veterinary research.
- Clenbuterol has no approved human use in the United States and is associated with hospital admissions for tachycardia and hypokalemia, not just fat loss.
- Rasmussen et al. (2016, European Heart Journal) found persistently reduced cardiac function in former anabolic steroid users years after stopping, suggesting some cardiovascular damage is not fully reversible.
- Stacking three oral androgens simultaneously, Anavar, Proviron, and Winstrol, multiplies hepatic stress in ways that a standard CMP does not fully capture.
- 8 IU of growth hormone daily in a non-deficient adult is associated with glucose dysregulation, soft tissue complications, and potential for acromegalic changes with sustained use per Blackman et al. (2002, JAMA).
- A 54,000-view disclosure of a high-risk stack, regardless of personal disclaimers, functions as a de facto blueprint for a general audience that does not share the creator's experience, monitoring access, or competitive context.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
trevor.wdavis · TikTok creator
54.6K views on this video
MY CURRENT CYCLE
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by trevor.wdavis, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.